Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The latest annual report into maternal deaths, produced by Oxford University researchers, highlights the risk of heart disease among pregnant women.

Pregnant woman © Shutterstock

Pregnant women and those who have recently given birth need to be aware of the symptoms of heart disease, says a major new report from researchers at the University of Oxford.

The latest Confidential Enquiry into Maternal Deaths from the national collaborative programme studying maternal and infant deaths, MBRRACE-UK, commissioned by the Healthcare Quality Improvement Partnership shows that in 2012-14, 8.5 women per 100,000* died during pregnancy or shortly after giving birth. The report, ‘Saving Lives, Improving Mothers’ Care’, highlights that two in every 100,000 died from heart disease, which is the leading cause of women dying in pregnancy or the early weeks after childbirth. There has been no significant change in the overall national maternal death rate since the last report.

Read more

Similar stories

Researchers develop machine learning algorithm to diagnose deep vein thrombosis

A team of researchers are developing the use of an artificial intelligence (AI) algorithm with the aim of diagnosing deep vein thrombosis (DVT) more quickly and as effectively as traditional radiologist-interpreted diagnostic scans, potentially cutting down long patient waiting lists and avoiding patients unnecessarily receiving drugs to treat DVT when they don’t have it.

COVID-19 recovery project nominated for HSJ award

The project, involving Oxford University Hospitals, Defence Medical Services (DMS), and the Radcliffe Department of Medicine is in the running for a prestigious honour at the Health Service Journal Awards 2021.

Oxford to assess revolutionary multi-cancer blood test in trial, for future implementation in the NHS

A partnership between the University of Oxford and GRAIL, LLC will evaluate the use of a new, non-invasive, multi-cancer early detection test known as Galleri in suspected cancer patients.

Blood bank storage can reduce ability of transfusions to treat anaemia

New research from Department of Physiology, Anatomy & Genetics (DPAG), in collaboration with NHS Blood and Transplant, has demonstrated that the process of storing blood in blood banks can negatively impact the function of red blood cells and consequently may reduce the effectiveness of blood transfusions, a treatment commonly used to combat anaemia.